Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 168 Records) |
Query Trace: ABL1[original query] |
---|
Genetic Variants of ABC and SLC Transporter Genes and Chronic Myeloid Leukaemia: Impact on Susceptibility and Prognosis. International journal of molecular sciences 2022 9 23 (17): . Alves Raquel, Gonçalves Ana Cristina, Jorge Joana, Marques Gilberto, Ribeiro André B, Tenreiro Rita, Coucelo Margarida, Diamond Joana, Oliveiros Bárbara, Pereira Amélia, Freitas-Tavares Paulo, Almeida António M, Sarmento-Ribeiro Ana Be |
Differences in Variants in the Structural Domain of BCR-ABL1 Kinase between Chinese Han and Minority Patients with Chronic Myeloid Leukemia by Sanger Sequencing and Next-Generation Sequencing. Cytogenetic and genome research 2022 9 162 (4): 201-206. Abulaiti Dilinazi, Tuerxun Niluopaer, Wang Huan, Abulizi Patiguli, Zhao Fang, Liu Yang, Hao Jianpi |
JAK2 V617f in chronic myeloid leukemia: driving force or passive bystander? Hematology (Amsterdam, Netherlands) 2022 8 27 (1): 842-846. Tarantini Francesco, Cumbo Cosimo, Zagaria Antonella, Parciante Elisa, Anelli Luisa, Coccaro Nicoletta, Tota Giuseppina, Minervini Crescenzio Francesco, Redavid Immacolata, Rossi Antonella Russo, Conserva Maria Rosa, Specchia Giorgina, Musto Pellegrino, Albano Frances |
ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia. Leukemia 2022 7 36 (9): 2242-2249. Schönfeld Lioba, Rinke Jenny, Hinze Anna, Nagel Saskia N, Schäfer Vivien, Schenk Thomas, Fabisch Christian, Brümmendorf Tim H, Burchert Andreas, le Coutre Philipp, Krause Stefan W, Saussele Susanne, Safizadeh Fatemeh, Pfirrmann Markus, Hochhaus Andreas, Ernst Thom |
Clinical characteristics, disease evolution and survival in patients with chronic myeloid leukemia, BCR-ABL1 (+) and T315I mutation. Folia medica 2022 7 63 (5): 670-675. Goranova-Marinova Veselina, Linev Alexander, Ivanov Hristo J, Zheljazkov Ivan, Stoyanova Vily, Grudeva-Popova Zhan |
Clinical features and next-generation sequencing landscape of essential thrombocythemia, prefibrotic primary myelofibrosis, and overt fibrotic primary myelofibrosis: a Chinese monocentric retrospective study. Journal of cancer research and clinical oncology 2022 6 . Zhang Lan, Ye Xingnong, Luo Shuna, Xu Xiaofei, Wang Shengjie, Jin Keyi, Zheng Yan, Zhu Xiaoqiong, Chen Dan, Jin Jie, Huang Ji |
Next-generation sequencing-based analysis to assess the pattern of relapse in patients with Philadelphia-positive acute lymphoblastic leukemia. EJHaem 2022 12 3 (4): 1145-1153. Ahn Jae-Sook, Kim TaeHyung, Jung Sung-Hoon, Ahn Seo-Yeon, Song Ga-Young, Kim Mihee, Yang Deok-Hwan, Lee Je-Jung, Kim Mi Yeon, Moon Joon Ho, Zhang Zhaolei, Kim Hyeoung-Joon, Kim Dennis Dong Hw |
BCR-ABL1 is a secondary event after JAK2V617F in a patient with essential thrombocythemia who develop chronic myeloid leukemia. Blood science (Baltimore, Md.) 2022 12 4 (4): 199-204. Zhang Yanqing, Bi Hailiang, Wang Ying, Chen Long, Pan Jiaqi, Xu Ping, Wang Wei, Yang Shaob |
Targeted Next-Generation Sequencing Identifies Additional Mutations Other than BCR?ABL in Chronic Myeloid Leukemia Patients: A Chinese Monocentric Retrospective Study. Cancers 2022 12 14 (23): . Hu Shiwei, Chen Dan, Xu Xiaofei, Zhang Lan, Wang Shengjie, Jin Keyi, Zheng Yan, Zhu Xiaoqiong, Jin Jie, Huang Ji |
Long-Term Molecular Remission after Treatment with Imatinib in a Chronic Myeloid Leukemia Patient with Extreme Thrombocytosis Harboring Rare e14a3 (b3a3) BCR::ABL1 Transcript: A Case Report. Current oncology (Toronto, Ont.) 2022 11 29 (11): 8171-8179. Zhang Xupai, Sun Haoping, Su Yi, Yi H |
Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia. Blood cancer journal 2022 10 12 (10): 144. Bidikian Aram, Kantarjian Hagop, Jabbour Elias, Short Nicholas J, Patel Keyur, Ravandi Farhad, Sasaki Koji, Issa Ghayas |
Impact of genetic polymorphisms of drug transporters ABCB1 and ABCG2 and regulators of xenobiotic transport and metabolism PXR and CAR on clinical efficacy of dasatinib in chronic myeloid leukemia. Frontiers in oncology 2022 12 952640. Madejczyk Anna Marta, Canzian Federico, Góra-Tybor Joanna, Campa Daniele, Sacha Tomasz, Link-Lenczowska Dorota, Florek Izabela, Prejzner Witold, Ca?becka M, Rymko M, Dudzi?ski M, Orzechowska Magdalena Julita, Jamroziak Krzyszt |
Exposure-Efficacy Analysis of Asciminib in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase. Clinical pharmacology and therapeutics 2022 Jul . Combes François Pierre, Li Ying Fei, Hoch Matthias, Lorenzo Sebastien, Ho Yu-Yun, Sy Sherwin K |
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort. Leukemia 2023 7 . Georgia Metzgeroth, Laurenz Steiner, Nicole Naumann, Johannes Lübke, Sebastian Kreil, Alice Fabarius, Claudia Haferlach, Torsten Haferlach, Wolf-Karsten Hofmann, Nicholas C P Cross, Juliana Schwaab, Andreas Reit |
Supratentorial Sporadic Hemangioblastoma: A Case Report With Mutation Profiling Using Next-Generation DNA Sequencing. Cureus 2023 6 15 (6): e39818. Mohiuddin M Taher, Najwa A Bantan, Mustafa H Alwalily, Muhammad Saeed, Nuha M Taher, Meriem Bouzidi, Raid A Jastania, Kamal B Balkhoyo |
[Genomics of next generation sequencing in pediatric B-acute lymphoblastic leukemia and its impact on minimal residual disease]. Zhonghua er ke za zhi = Chinese journal of pediatrics 2023 6 61 (6): 527-532. Y Y Gao, Y J Jia, B Q Qi, X Y Zhang, Y M Chen, Y Zou, Y Guo, W Y Yang, L Zhang, S C Wang, R R Zhang, T F Liu, Z Song, X F Zhu, X J Ch |
Genetic alterations in the BCR-ABL1 fusion gene related to imatinib resistance in chronic myeloid leukemia. Leukemia research 2023 6 131 107325. Macario Martínez-Castillo, Laura Gómez-Romero, Hugo Tovar, Irma Olarte-Carrillo, Anel García-Laguna, Gilberto Barranco-Lampón, Adrián De la Cruz-Rosas, Adolfo Martínez-Tovar, Araceli Hernández-Zavala, Emilio J Córdo |
Genomic profiling of idiopathic peri-hilar cholangiocarcinoma reveals new targets and mutational pathways. Scientific reports 2023 4 13 (1): 6681. Leonard M Quinn, Sam Haldenby, Philip Antzcak, Anna Fowler, Katie Bullock, John Kenny, Timothy Gilbert, Timothy Andrews, Rafael Diaz-Nieto, Stephen Fenwick, Robert Jones, Eithne Costello-Goldring, Graeme Poston, William Greenhalf, Daniel Palmer, Hassan Malik, Chris Goldri |
Comparison of clinicopathological and genomic profiles in anal squamous cell carcinoma between Japanese and Caucasian cohorts. Scientific reports 2023 3 13 (1): 3587. Ito Takahiko, Takayanagi Daisuke, Sekine Shigeki, Hashimoto Taiki, Shimada Yoko, Matsuda Maiko, Yamada Masayoshi, Hamamoto Ryuji, Kato Tomoyasu, Shida Dai, Kanemitsu Yukihide, Boku Narikazu, Kohno Takashi, Takashima Atsuo, Shiraishi Kou |
Droplet digital polymerase chain reaction improves the detection of BCR-ABL1 kinase domain mutation in Philadelphia chromosome-positive acute lymphoblastic leukemia. International journal of laboratory hematology 2023 3 . Wan Li, Ma Jiao, Gong Xiaoyuan, Li Qinghua, Wang Ying, Wei Hui, Wang Jianxiang, Xiao Zhijian, Mi Yingcha |
Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention. Haematologica 2023 3 . Shanmuganathan Naranie, Wadham Carol, Shahrin NurHezrin, Feng Jinghua, Thomson Daniel, Wang Paul, Saunders Verity, Kok Chung Hoow, King Rob M, Kenyon Rosalie R, Lin Ming, Pagani Ilaria S, Ross David M, Yong Agnes S M, Grigg Andrew P, Mills Anthony K, Schwarer Anthony P, Braley Jodi, Altamura Haley, Yeung David T, Scott Hamish S, Schreiber Andreas W, Hughes Timothy P, Branford Sus |
Prostate Cancer Patient Stratification by Molecular Signatures in the Veterans Precision Oncology Data Commons. Cold Spring Harbor molecular case studies 2023 12 . Kyle M Hernandez, Aarti Venkat, Danne C Elbers, John R Bihn, Mary T Brophy, Nhan V Do, Jennifer La, Qiong Liu, Andrew Prokhorenkov, Noah Metoki-Shlubsky, Feng-Chi Sung, Channing J Paller, Nathanael R Fillmore, Robert L Grossm |
Molecular landscape of the JAK2 gene in chronic myeloproliferative neoplasm patients from the state of Amazonas, Brazil. Biomedical reports 2023 11 19 (6): 98. Dania G Torres, Emanuela V Barbosa Alves, Miliane Araújo de Sousa, Wanessa H Laranjeira, Jhemerson Paes, Erycka Alves, Deborah Canté, Allyson G Costa, Adriana Malheiro, Rosângela Abreu, Leny Nascimento, Nelson A Fraiji, George A V Silva, Lucivana P de Souza Mourão, Andréa M Tarra |
Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations. Human genomics 2023 1 17 (1): 2. Kim Jinyong, Jeong Kyeonghun, Jun Hyeji, Kim Kwangsoo, Bae Jeong Mo, Song Myung Geun, Yi Hanbaek, Park Songyi, Woo Go-Un, Lee Dae-Won, Kim Tae-Yong, Lee Kyung-Hun, Im Seock- |
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. Cancers 2023 1 15 (2): . Sargas Claudia, Ayala Rosa, Larráyoz María José, Chillón María Carmen, Carrillo-Cruz Estrella, Bilbao-Sieyro Cristina, Prados de la Torre Esther, Martínez-Cuadrón David, Rodríguez-Veiga Rebeca, Boluda Blanca, Gil Cristina, Bernal Teresa, Bergua Juan Miguel, Algarra Lorenzo, Tormo Mar, Martínez-Sánchez Pilar, Soria Elena, Serrano Josefina, Alonso-Domínguez Juan Manuel, García-Boyero Raimundo, Amigo María Luz, Herrera-Puente Pilar, Sayas María José, Lavilla-Rubira Esperanza, Martínez-López Joaquín, Calasanz María José, García-Sanz Ramón, Pérez-Simón José Antonio, Gómez-Casares María Teresa, Sánchez-García Joaquín, Barragán Eva, Montesinos Pau, On Behalf Of Pethema Grou |
Prognostic significance of steroid response in pediatric acute lymphoblastic leukemia: The CCCG-ALL-2015 study. Frontiers in oncology 2023 1 12 1062065. Chu Jinhua, Cai Huaju, Cai Jiaoyang, Bian Xinni, Cheng Yumei, Guan Xianmin, Chen Xiaoqian, Jiang Hua, Zhai Xiaowen, Fang Yongjun, Zhang Lei, Tian Xin, Zhou Fen, Wang Yaqin, Wang Lingzhen, Li Hong, Kwan Alex Leung Wing, Yang Minghua, Yang Hanfang, Zhan Aijun, Wang Ningling, Hu Shaoy |
Prevalence and clinicopathological features of driver gene mutations profile in BCR: ABL1 negative classical myeloproliferative neoplasm-A single-center study from North India. Indian journal of pathology & microbiology 2024 5 . Khaliqur Rahman, Seema Biswas, Akhilesh Sharma, Kusum Gupta, Dinesh Chandra, Manish K Singh, Ruchi Gupta, Ashish Mishra, Sanjeev Kumar, Anshul Gupta, Faheema Hasan, Soniya Nityanand, Rajesh Kahsy |
A comparative analysis of the clinical and genetic profiles of blast phase BCR::ABL1-negative myeloproliferative neoplasm and acute myeloid leukemia, myelodysplasia-related. International journal of laboratory hematology 2024 4 . Dong Chen, Julia Geyer, Adam Bagg, Robert Hasserjian, Olga K Weinbe |
Exploring hematological alterations and genetics linked to SNV rs10974944 in myeloproliferative neoplasms among Amazon patients. Scientific reports 2024 4 14 (1): 9389. Jhemerson F Paes, Dania G Torres, Deborah C Aquino, Emanuela V B Alves, Erycka A Mesquita, Miliane A Sousa, Nelson Abrahim Fraiji, Leny N M Passos, Rosângela S Abreu, George A V Silva, Andréa M Tarragô, Lucivana P de Souza Mour |
IKZF1 alterations contribute to outcome disparities in Hispanic/Latino children with B-lymphoblastic leukemia. Pediatric blood & cancer 2024 4 e30996. Alexandra E Kovach, Maximilian Wengyn, My H Vu, Andrew Doan, Gordana Raca, Deepa Bhojwa |
- Page last reviewed:Feb 1, 2024
- Page last updated:Jun 03, 2024
- Content source: